The defendants are drugmakers Eli Lilly, Novo Nordisk and Sanofi-Aventis; PBM Evernorth Health; Express Scripts and its subsidiaries Medco Health Solutions and Esi Mail Pharmacy Services; CVS Health and CVS Caremark; and UnitedHealth Group and its businesses Optum, OptumRx and OptumInsight.
The city filed the suit July 24.
“Diabetics need insulin to stay alive,” Cleveland officials said in a news release. “The defendants exploit this reality to guarantee their price-fixing scheme, making insulin unaffordable to individuals and resulting in exorbitant costs for prescription benefit sponsors like the city of Cleveland.”
A CVS spokesperson called the case “baseless” and an Eli Lilly spokesperson said it was “meritless.” Evernorth did not respond to Becker’s request for comment.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.